Phio Pharmaceuticals Corp.·4

Sep 13, 3:00 PM ET

Infarinato Robert M. 4

4 · Phio Pharmaceuticals Corp. · Filed Sep 13, 2024

Insider Transaction Report

Form 4
Period: 2024-09-11
Infarinato Robert M.
VP, Chief Financial Officer
Transactions
  • Award

    Common Stock, $0.0001 Par Value

    2024-09-11+3,00011,000 total
Footnotes (2)
  • [F1]Represents shares underlying a restricted stock unit, which shares will vest in one year on the first anniversary.
  • [F2]Includes shares of common stock underlying unvested restricted stock units.

Documents

1 file
  • 4
    ownership.xmlPrimary